Biotechnology and the Labeling Dilemma

DSpace/Manakin Repository

dc.contributor.advisor	Hutt, Peter Barton	en_US
dc.contributor.author	Choi, Adela M.	en_US
dc.date.accessioned	2012-06-07T05:03:56Z
dc.date.issued	2001	en_US
dc.identifier.citation	Biotechnology and the Labeling Dilemma (2001 Third Year Paper)	en
dc.identifier.uri	http://nrs.harvard.edu/urn-3:HUL.InstRepos:8846803
dc.description.abstract	This paper will examine the arguments and motivations underlying the FDA stand against mandatory labeling of genetically engineered foods and ingredients. Part I of the paper will describe FDAâ€™s current regulatory policy towards genetically engineered foods. Part II will advance the theoretical basis for the labeling argument. Part III will explore the FDA and industryâ€™s arguments against labeling. Part IV will evaluate those FDA and industry responses. Part V will examine how predictions about public risk perceptions may have shaped the FDAâ€™s labeling stance. Finally, Part VI will examine the realities facing the government and industry that may affect the direction of labeling policy in the future.	en
dc.language.iso	en_US	en
dash.license	LAA	en_US
dc.subject	Food and Drug Law	en
dc.subject	biotechnology	en
dc.subject	genetically engineered food	en
dc.subject	gm food	en
dc.subject	FDA	en
dc.subject	labeling	en
dc.title	Biotechnology and the Labeling Dilemma	en
dc.type	Paper (for course/seminar/workshop)	en_US
dc.date.available	2012-06-07T05:03:56Z